Status:
COMPLETED
Intrauterine Insemination and Luteal Fase Support
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Infertility
Eligibility:
FEMALE
18-43 years
Phase:
PHASE4
Brief Summary
The objective is to test the hypothesis that luteal phase support with vaginal progesterone leads to a higher clinical pregnancy rate (primary outcome) and live birth rate (secondary outcome) when com...
Eligibility Criteria
Inclusion
- Patients with an indication for IUI:
- unexplained infertility
- mild male factor infertility
- minimal-mild endometriosis
- Women:
- first IUI cycle ever
- normal ovulatory cycles (26-32d)
- age\<43,BMI≤30
- presence of at least one patent tube on hysterosalpingography and/or laparoscopy
- normal uterine cavity (ultrasound, hysterosalpingography, or laparoscopy)
- Men: Total motile count ≥ 5 Million/ml after capacitation
Exclusion
- Patients with contra-indication for pregnancy , infertility or progesterone use.
Key Trial Info
Start Date :
April 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
393 Patients enrolled
Trial Details
Trial ID
NCT01826747
Start Date
April 1 2011
End Date
June 1 2016
Last Update
October 19 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ Leuven
Leuven, Belgium, 3000